These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12801229)

  • 1. Discovery of a potent and selective protein kinase CK2 inhibitor by high-throughput docking.
    Vangrevelinghe E; Zimmermann K; Schoepfer J; Portmann R; Fabbro D; Furet P
    J Med Chem; 2003 Jun; 46(13):2656-62. PubMed ID: 12801229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA).
    Sarno S; de Moliner E; Ruzzene M; Pagano MA; Battistutta R; Bain J; Fabbro D; Schoepfer J; Elliott M; Furet P; Meggio F; Zanotti G; Pinna LA
    Biochem J; 2003 Sep; 374(Pt 3):639-46. PubMed ID: 12816539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and characterization of a substrate selective p38alpha inhibitor.
    Davidson W; Frego L; Peet GW; Kroe RR; Labadia ME; Lukas SM; Snow RJ; Jakes S; Grygon CA; Pargellis C; Werneburg BG
    Biochemistry; 2004 Sep; 43(37):11658-71. PubMed ID: 15362850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of Rho kinase inhibitors (I).
    Takami A; Iwakubo M; Okada Y; Kawata T; Odai H; Takahashi N; Shindo K; Kimura K; Tagami Y; Miyake M; Fukushima K; Inagaki M; Amano M; Kaibuchi K; Iijima H
    Bioorg Med Chem; 2004 May; 12(9):2115-37. PubMed ID: 15080913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of the catalytic subunit of protein kinase CK2 from Zea mays at 2.1 A resolution.
    Niefind K; Guerra B; Pinna LA; Issinger OG; Schomburg D
    EMBO J; 1998 May; 17(9):2451-62. PubMed ID: 9564028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of ellagic acid as potent inhibitor of protein kinase CK2: a successful example of a virtual screening application.
    Cozza G; Bonvini P; Zorzi E; Poletto G; Pagano MA; Sarno S; Donella-Deana A; Zagotto G; Rosolen A; Pinna LA; Meggio F; Moro S
    J Med Chem; 2006 Apr; 49(8):2363-6. PubMed ID: 16610779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of protein kinase CK2 as a potent kinase of Epstein-Barr virus latent membrane protein 1.
    Chi LM; Yu JS; Chang YS
    Biochem Biophys Res Commun; 2002 Jun; 294(3):586-91. PubMed ID: 12056807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of natural product-derived receptor tyrosine kinase inhibitors based on conservation of protein domain fold.
    Kissau L; Stahl P; Mazitschek R; Giannis A; Waldmann H
    J Med Chem; 2003 Jul; 46(14):2917-31. PubMed ID: 12825933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coumarin as attractive casein kinase 2 (CK2) inhibitor scaffold: an integrate approach to elucidate the putative binding motif and explain structure-activity relationships.
    Chilin A; Battistutta R; Bortolato A; Cozza G; Zanatta S; Poletto G; Mazzorana M; Zagotto G; Uriarte E; Guiotto A; Pinna LA; Meggio F; Moro S
    J Med Chem; 2008 Feb; 51(4):752-9. PubMed ID: 18251491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell cycle regulatory protein p27KIP1 is a substrate and interacts with the protein kinase CK2.
    Tapia JC; Bolanos-Garcia VM; Sayed M; Allende CC; Allende JE
    J Cell Biochem; 2004 Apr; 91(5):865-79. PubMed ID: 15034923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced binding of RNAP II CTD phosphatase FCP1 to RAP74 following CK2 phosphorylation.
    Abbott KL; Renfrow MB; Chalmers MJ; Nguyen BD; Marshall AG; Legault P; Omichinski JG
    Biochemistry; 2005 Mar; 44(8):2732-45. PubMed ID: 15723518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect and its kinetic analysis of tyrphostin AG1478 on recombinant human protein kinase CK2 holoenzyme.
    Liu XG; Liang NC
    Acta Pharmacol Sin; 2002 Jun; 23(6):556-61. PubMed ID: 12060532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GTP plus water mimic ATP in the active site of protein kinase CK2.
    Niefind K; Pütter M; Guerra B; Issinger OG; Schomburg D
    Nat Struct Biol; 1999 Dec; 6(12):1100-3. PubMed ID: 10581548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus NS2 protein is phosphorylated by the protein kinase CK2 and targeted for degradation to the proteasome.
    Franck N; Le Seyec J; Guguen-Guillouzo C; Erdtmann L
    J Virol; 2005 Mar; 79(5):2700-8. PubMed ID: 15708989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole: a novel powerful and selective inhibitor of protein kinase CK2.
    Pagano MA; Meggio F; Ruzzene M; Andrzejewska M; Kazimierczuk Z; Pinna LA
    Biochem Biophys Res Commun; 2004 Sep; 321(4):1040-4. PubMed ID: 15358133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase CK2 phosphorylates the cell cycle regulatory protein Geminin.
    Kulartz M; Hiller E; Kappes F; Pinna LA; Knippers R
    Biochem Biophys Res Commun; 2004 Mar; 315(4):1011-7. PubMed ID: 14985113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The catalytic subunit of human protein kinase CK2 structurally deviates from its maize homologue in complex with the nucleotide competitive inhibitor emodin.
    Raaf J; Klopffleisch K; Issinger OG; Niefind K
    J Mol Biol; 2008 Mar; 377(1):1-8. PubMed ID: 18242640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The raison d'être of constitutively active protein kinases: the lesson of CK2.
    Pinna LA
    Acc Chem Res; 2003 Jun; 36(6):378-84. PubMed ID: 12809523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of dibenzo[c,f][2,7]naphthyridines as potent and selective 3-phosphoinositide-dependent kinase-1 inhibitors.
    Gopalsamy A; Shi M; Boschelli DH; Williamson R; Olland A; Hu Y; Krishnamurthy G; Han X; Arndt K; Guo B
    J Med Chem; 2007 Nov; 50(23):5547-9. PubMed ID: 17941624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based design of novel potent protein kinase CK2 (CK2) inhibitors with phenyl-azole scaffolds.
    Hou Z; Nakanishi I; Kinoshita T; Takei Y; Yasue M; Misu R; Suzuki Y; Nakamura S; Kure T; Ohno H; Murata K; Kitaura K; Hirasawa A; Tsujimoto G; Oishi S; Fujii N
    J Med Chem; 2012 Mar; 55(6):2899-903. PubMed ID: 22339433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.